Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Oil Prices Dip on US-Iran Pause; AstraZeneca Boosted by Cancer Drug Sales

Global oil prices have seen a notable decline following a temporary de-escalation in tensions between the US and Iran, offering a fragile hope for stability. Meanwhile, pharmaceutical giant AstraZeneca has outperformed profit forecasts, buoyed by strong demand for its cancer treatments.

  • Brent crude oil prices fell 5.3% to $91.68 a barrel after Iran paused 'retaliatory' attacks.
  • AstraZeneca reported an 18% rise in Q2 earnings per share, driven by cancer treatment sales.
  • Chinese fast fashion retailer Shein recorded a $99 million net loss in Q1 2026 due to US import duty changes.

International oil prices experienced a significant dip on Monday, with Brent crude, the global benchmark, falling 5.3% to $91.68 a barrel. This comes after reaching $100 last week and follows an announcement from Iran on Sunday that it would pause 'retaliatory' attacks against US allies in the region. The move has been interpreted by analysts, including Jim Reid of Deutsche Bank, as an 'opportunity for diplomacy,' despite US officials maintaining that all military options remain on the table. The situation, however, remains volatile, with ongoing disruptions to shipping in both the Strait of Hormuz and the Red Sea, where Iran-backed Houthi forces have reportedly continued attacks on Saudi energy infrastructure.

For UK households and businesses, a sustained reduction in oil prices could offer some relief from inflationary pressures. Cheaper crude oil typically translates to lower costs at the pump for motorists and reduced energy bills for businesses, potentially easing the squeeze on consumer spending and operational expenses. The Bank of England closely monitors energy prices as a key factor in its monetary policy decisions, and any sustained decline could influence future interest rate considerations, impacting mortgage holders and savers across the country.

In other significant business news, pharmaceutical giant AstraZeneca announced better-than-expected profits for its second quarter. The company reported an 18% increase in earnings per share to $2.63 (£1.97) for the three months ending June, with overall revenue rising 5% to $15.38 billion at constant currency. This strong performance was primarily attributed to robust sales of its cancer treatments, underscoring the company's strategic focus on oncology. AstraZeneca's positive results could provide a boost to the FTSE 100, where it is a significant constituent, potentially benefiting UK investors with holdings in broad market trackers or direct shares.

Conversely, Chinese fast fashion behemoth Shein revealed a net loss of $99 million (£74.1 million) in its first quarter of 2026, a stark contrast to the $395 million net income reported a year prior. This downturn follows the removal of a crucial import duty exemption for small packages in the US, which triggered a slowdown in sales. Shein, currently preparing for a potential listing on Hong Kong's stock exchange, stated it is exploring options including increasing prices in the US to offset rising costs. Furthermore, the European Union recently imposed a €3 fee on low-value e-commerce imports, a measure designed to protect European businesses from what it terms 'unfair competition' from China, indicating a broader shift in global trade policies.

The challenges faced by Shein highlight a potential shift in the global e-commerce landscape, as governments increasingly scrutinise and regulate international online trade. For UK consumers, this could eventually lead to higher prices for goods imported from certain regions as retailers pass on increased costs. For UK businesses, particularly those in the retail sector, these developments underscore the evolving competitive environment and the importance of adapting to changing international trade policies and consumer preferences.

Why this matters: Fluctuations in global oil prices directly influence UK inflation and household budgets, while the performance of major UK-listed companies like AstraZeneca affects investor confidence and pension values. Changes in international trade policies also impact the cost and availability of goods for UK consumers.

What this means for you: Lower oil prices could mean cheaper petrol and potentially lower utility bills, easing living costs. If you have a pension or investments in the FTSE 100, AstraZeneca's strong performance could positively impact their value, while changes to import duties might eventually increase the cost of some online purchases.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.